Abstract
To analyze the role of individual glycosylation pattern on PRL biopotency, monomeric prolactin (PRL), secreted by human prolactinoma cells in culture, was isolated by gel filtration and separated by affinity chromatography on Concanavalin A-Sepharose or Lentil-Agarose. These lectins allowed the isolation of PRL glycoforms containing either biantennary, mannose-rich or fucosylated complexcarbohydrate structures, respectively. Endoglycosidase treatment and carbohydrate content of PRL was found to be consistent with N-linked oligosaccharides of mannose-rich structure and complex units terminated in sialic acid. Mannose-rich PRL and PRL with biantennary oligosaccharides promoted cell growth of rat lymphoma cells to a diminished extent compared to non-glycosylated PRL (NG-PRL), indicating that the two major types of carbohydrate structure are able to decrease the intrinsic bioactivity of PRL. Metabolic clearance of the various forms of PRL in rats was also found to be highly dependent upon hormone glycosylation. The various glycosylated forms (G-PRLs) proved to be totally eliminated from the circulation within 60 min, faster than NG-PRL 10% of which was still present at that time. Mannose-rich or biantennary G-PRLs were differentially cleared in a biphasial fashion with a similar rapid phase of about 2 min followed by distinct slow phases of 12 and 27 min, respectively. The presence of fucose did not alter this distribution. In contrast, NG-PRL was eliminated with a half-time of approximately 5 min, followed by a very slow disappearance over several h. It thus appeared that glycosylation increased the metabolic clearance rate of PRL from 0.13±0.07ml/min for NG-PRL to 0.47±0.12 ml/min for PRL with biantennary carbohydrate chains and 0.8±0.2 ml/min for the hormone with mannose-rich oligosaccharides. The distribution of PRL to target and elimination organs was also found to be different according to the carbohydrate structure present in the hormone. NG-PRL and mannose-rich G-PRL showed higher incorporation in liver than biantennary G-PRL which was preferentially eliminated by the kidney. Altogether, the current data show that addition of oligosaccharides to PRL as well as carbohydrate structure contribute to modulate both the duration of the hormone in the blood and its distribution to different organs. It is proposed that glycosylation may selectively down-regulate PRL action at individual target tissues.
Similar content being viewed by others
Abbreviations
- CHO:
-
carbohydrate
- GalNAc:
-
N-acetylgalactosamine
- GlcNAc:
-
N-acetylglucosamine
- Gal:
-
galactose
- Fuc:
-
fucose
- S04:
-
sulfate
- Con A:
-
Concanavalin A
- LCA:
-
Lens communis Agglutinin
- Neu Ac:
-
neuraminic acid (salic acid)
- h:
-
human
- PRL:
-
prolactin
- G-PRL:
-
glycosylated prolactin
- NG-PRL:
-
non-glycosylated prolactin
- TSH:
-
Thyroid-Stimulating-Hormone
- LH:
-
lutropin
- CG:
-
chorionic gonadotropin
- MCR:
-
metabolic clearance rate
- mAb:
-
monoclonal antibody
- Nb2:
-
rat node lymphoma cells
- IRMA:
-
immunoradiometric assay
- KD:
-
kilodalton
- Endo:
-
endoglycosidase
References
Sinha Y.N. Prolactin variants. TEM 3:100, 1992.
Meuris S., Svobota M. Physiological relevance of pituitary and non-pituitary prolactins. Evidence for a glycosylated prolactin variant in human pituitary and amniotic fluid. Cristophe J. and Robyn C. (1985). Prolactin basic and clinical correlates Fidia Research Series vol. 1 Livinia Press, Padova, Section VII, p428–493.
Lewis U.J., Singh R.N.P., Sinha Y.N., Vanderlaan W.P. Glycosylated human prolactin. Endocrinology 116: 353, 1985.
Bollengier F., Houghe R., Velkeniers B., Mahler A., Vanhaelst L., Hooghe-Peters. Further characterization of rat 26,000 prolactin as a glycoprotein with essentially O-linked carbohydrate chains. J. Neuroendocrinol. 3: 375, 1991.
Sinha Y.N., Depaolo L.V., Haro L.S., Singh R.N.P., Jacobsen B.P., Scott K.E., Lewis U.J. Isolation and biochemical properties of four forms of glycosylated porcine prolactin. Mol. Cell. Endocrinol. 80: 203, 1991.
Hoffmann T., Brue T., Gunz G., Ronin C, Jaquet P. Prolactin isoforms secreted by human prolactinomas. Hormone Res in press (1993).
Ronin C. Glycosylation of pituitary hormones: a necessary multistep control of biopotency. Glycoconjugate. J. 9: 279, 1992.
Smith P.L., Baenziger J.U. The sialylated oligosaccharides of recombinant bovine lutropin modulate hormone bioactivity. J. Biol. Chem. 265: 874, 1991.
Baenziger J.U., Kuman S., Brodbeck R.M., Smith P.L., Beranek M.C. Circulatory half-life but not interaction with the lutropin/ chorionic gonadotropin receptor is modulated by sulfation of bovin lutropin oligosaccharides. Proc. Natl. Acad. Sci. 89: 334, 1992.
Pellegrini I., Gunz G., Fenouillet E., Peyart J.P., Delori P., Ronin C, Jaquet P. Polymorphism of prolactin secreted by human prolactinoma cells: Immunological, receptor binding and biological properties of the glycosylated and non-glycosylated forms. Endocrinology 122: 2667, 1988.
Brue T., Caruso E., Morange I., Hoffmann T., Evrin M., Gunz G., Benkirane M., Jaquet P. Immunoradiometric analysis of circulating human glycosylated and non-glycosylated prolactin forms: spontaneous and stimulated secretion. J. Clin. Endocrinol. Metab. 5: 1338, 1992.
Dunne A. Yana: A new iterative polyexponential curve stripping program. Comput. Meth. Prog. Biomed. 20: 269, 1985.
Olsson D.M., Nelson L.S. The Nelder-mead simplex procedure for function minimization. Technometrics 17: 45, 1975.
Distefano III J.J., Feng D. Comparative aspects of the distribution, metabolism and excretion of six iodotyrosines in the rat. Endocrinology 123: 2514, 1988.
Kelly P.A., Djiane J., Edery M. Different forms of prolactin receptors. TEM 3: 54, 1992.
Bernareggi A., Rowland M. Physiologic Modeling of cyclosporin kinetics in rat and man. J. Pharmacokin. Biopharm. 19: 21, 1991.
Miura Y., Perkel V.S., Papenberg K.A., Johnson M.J., Magner J. Concanavalin A, lentil, and ricin affinity binding characteristics of human thyrotropin. J. Clin. Endocrinol. Metab. 69: 985, 1989.
Skelto T.P., Kumar S., Smith P.L., Beranek M.C., Baezinger J.U. Pro-opiomelanocortin synthesized by corticotrophs bears asparagine-linked oligosacchararides terminating with S04-4 GalNAc. J. Biol. Chem. 267: 12998, 1992.
Sairam M.R. Glycoprotein hormone signal transduction. FASEB J. 3: 1915, 1989.
Pellegrini I., Gunz G., Jaquet P. Different pathways of secretion for glycosylated and nonglycosylated human prolactin. Endocrinology 126: 1087, 1989.
De Vos A.M., Ultsch M., Kossiakoff A.A. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255: 306, 1992.
Gesundheit N., Magner J., Chen J., Weintraub B.D. Differential sulfatation and sialylation of secreted mouse thyrotropin subunits: regulation by TRH. Endocrinology 119: 455, 1986.
Hiyama J., Weissshaar G., Renwick A.G.C. The asparagine-linked oligosaccharides at individual glycosylation sites in human thyrotrophin. Glycobiology 2: 401, 1992.
Smith P.L, Baenziger J.U. Molecular basis of recognition by the glycoprotein hormone-specific N-acetylgalactosamine transferase Proc. Natl. Acad. Sci. USA 9: 329, 1992.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hoffmann, T., Penel, C. & Ronin, C. Glycosylation of human prolactin regulates hormone bioactivity and metabolic clearance. J Endocrinol Invest 16, 807–816 (1993). https://doi.org/10.1007/BF03348932
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03348932